Cited 0 times in Scipus Cited Count

Increased Anti-Allergic Effects of Secretome of Low-Level Light Treated Tonsil-Derived Mesenchymal Stem Cells in Allergic Rhinitis Mouse Model

DC Field Value Language
dc.contributor.authorPark, IS-
dc.contributor.authorKim, DK-
dc.contributor.authorKim, JH-
dc.contributor.authorBae, JS-
dc.contributor.authorKim, EH-
dc.contributor.authorYoo, SH-
dc.contributor.authorChung, YJ-
dc.contributor.authorLyu, L-
dc.contributor.authorMo, JH-
dc.date.accessioned2023-02-27T07:12:51Z-
dc.date.available2023-02-27T07:12:51Z-
dc.date.issued2022-
dc.identifier.issn1945-8924-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24885-
dc.description.abstractBACKGROUND: Low-level light therapy (LLLT) is widely used for the photobiomodulation of cell behavior. Recent studies have shown that LLLT affects the proliferation and migration of various types of mesenchymal stem cells (MSCs). However, there is a lack of studies investigating the effect of LLT on enhancing the immunomodulatory properties of tonsil-derived MSCs (T-MSCs). OBJECTIVE: The aim of this study was to investigate the immunomodulatory effects of conditioned media from T-MSCs (T-MSCs-CM) treated with LLLT in allergic inflammation. METHODS: We isolated T-MSCs from human palatine tonsils and evaluated the ingredients of T-MSCs-CM. The effect of T-MSCs-CM treated with LLLT was evaluated in a mouse model of allergic rhinitis (AR). We randomly divided the mice into four groups (negative control, positive control, T-MSCs-CM alone, and T-MSCs-CM treated with LLLT). To elucidate the therapeutic effect, we assessed rhinitis symptoms, serum immunoglobulin (Ig), the number of inflammatory cells, and cytokine expression. RESULTS: We identified increased expression of immunomodulatory factors, such as HGF, TGF-beta, and PGE, in T-MSCs-CM treated with LLLT, compared to T-MSCs-CM without LLLT. Our animal study demonstrated reduced allergic symptoms and lower expression of total IgE and OVA-specific IgE in the LLLT-treated T-MSCs-CM group compared to the AR group and T-MSCs-CM alone. Moreover, we found that T-MSCs-CM treated with LLLT showed significantly decreased infiltration of eosinophils, neutrophils, and IL-17 cells in the nasal mucosa and reduced IL-4, IL-17, and IFN-gamma expression in OVA-incubated splenocytes compared to the AR group. CONCLUSIONS: The present study suggests that T-MSCs-CM treated with LLLT may provide an improved therapeutic effect against nasal allergic inflammation than T-MSCs-CM alone.-
dc.language.isoen-
dc.subject.MESHAnimals-
dc.subject.MESHAnti-Allergic Agents-
dc.subject.MESHCytokines-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHMesenchymal Stem Cells-
dc.subject.MESHMice-
dc.subject.MESHMice, Inbred BALB C-
dc.subject.MESHNasal Mucosa-
dc.subject.MESHOvalbumin-
dc.subject.MESHPalatine Tonsil-
dc.subject.MESHRhinitis, Allergic-
dc.subject.MESHSecretome-
dc.titleIncreased Anti-Allergic Effects of Secretome of Low-Level Light Treated Tonsil-Derived Mesenchymal Stem Cells in Allergic Rhinitis Mouse Model-
dc.typeArticle-
dc.identifier.pmid34738483-
dc.subject.keywordallergic-
dc.subject.keywordlaser-
dc.subject.keywordrhinitis-
dc.subject.keywordstem cell-
dc.subject.keywordtonsil-
dc.contributor.affiliatedAuthorPark, IS-
dc.type.localJournal Papers-
dc.identifier.doi10.1177/19458924211053762-
dc.citation.titleAmerican journal of rhinology & allergy-
dc.citation.volume36-
dc.citation.number2-
dc.citation.date2022-
dc.citation.startPage261-
dc.citation.endPage268-
dc.identifier.bibliographicCitationAmerican journal of rhinology & allergy, 36(2). : 261-268, 2022-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1945-8932-
dc.relation.journalidJ019458924-
Appears in Collections:
Journal Papers > Research Organization > Cell Therapy Center
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse